You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 4,076,831


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,076,831
Title: Pyrano[3,4-b]-indole derivatives, pharmaceutical compositions and methods of use
Abstract:Indole derivatives characterized by having a 1,3,4,9-tetrahydropyrano[3,4-b]indole or 1,3,4,9-tetrahydrothiopyrano[3,4-b]indole nucleus bearing a substituent in position 1, said substituent incorporating an acid, ester or amide function therein, are disclosed. The nucleus is further substituted at position 1 and may be optionally substituted at positions 3, 4, 5, 6, 7, 8, and 9. The derivatives are useful antiinflammatory, analgesic, antibacterial and antifungal agents and methods for their preparation and use are also disclosed.
Inventor(s): Demerson; Christopher A. (Montreal, CA), Humber; Leslie G. (Dollard des Ormeaux, CA), Dobson; Thomas A. (Dollard des Ormeaux, CA), Jirkovsky; Ivo L. (Montreal, CA)
Assignee: American Home Products Corporation (New York, NY)
Application Number:05/749,931
Patent Claims: 1. A compound of the formula Ia ##STR129## in which R.sup.1 is selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl, lower cycloalkyl, phenyl, benzyl and 2-thienyl, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are the same or different and are each selected from the group consisting of hydrogen and lower alkyl, R.sup.6a, R.sup.6b, R.sup.6c, and R.sup.6d are the same or different and selected from the group consisting of lower cycloalkyl and phenyl R.sup.7 is selected from the group consisting of hydrogen, lower alkyl and lower alkenyl, X is selected from the group consisting of oxy and thio, Y is selected from the group consisting of carbonyl, ##STR130## which each of R.sup.8, R.sup.9, R.sup.10, R.sup.11 , R.sup.12 and R.sup.13 is hydrogen or lower alkyl, and Z is selected from the group consisting of hydroxy and lower alkoxy.

2. 8-Cyclopropyl-1-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid, as claimed in claim 1.

3. 8-Cyclopentyl-1-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid, as claimed in claim 1.

4. 8-Cyclohexyl-1-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid, as claimed in claim 1.

5. 1-Ethyl-8-phenyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid, as claimed in claim 1.

6. A method of treating inflammation in a warm-blooded animal, comprising: administering perorally to said animal an antiinflammatorily effective amount of the compound of the following formula Ib ##STR131## in which R.sup.1 is selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl, lower cycloalkyl, phenyl, benzyl and 2-thienyl, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are the same or different and are each selected from the group consisting of hydrogen and lower alkyl, R.sup.6a, R.sup.6b, R.sup.6c, and R.sup.6d are the same or different and selected from the group consisting of hydrogen, lower alkyl, lower cycloalkyl, hydroxy, lower alkoxy, benzyloxy, lower alkanoyloxy, phenyl, nitro, halo, mercapto, lower alkylthio, trifluoromethyl, amino and sulfamoyl, R.sup.7 is selected from the group consisting of hydrogen, lower alkyl and lower alkenyl, X is selected from the group consisting of oxy and thio, Y is selected from the group consisting of carbonyl, ##STR132## which each of R.sup.8, R.sup.9, R.sup.10, R.sup.11, R.sup.12 and R.sup.13 is hydrogen or lower alkyl, and Z is selected from the group consisting of hydroxy and lower alkoxy.

7. A method of producing analgesia in a warm-blooded animal, comprising: administering perorally to said animal an analgesically effective amount of the compound of formula 1b of claim 6.

8. A pharmaceutical composition comprising: an anti-inflammatory effective amount of the compound of formula 1b of claim 6 and a pharmaceutically acceptable carrier.

9. A pharmaceutical composition, comprising: an analgesically effective amount of the compound of Formula 1b of claim 6 and a pharmaceutically acceptable carrier.

10. A method according to claim 6 wherein 1-propyl-1,3,4,9,tetrahydropyrano[3,4-b]indole-1-acetic acid is the compound administered.

11. A method according to claim 6 wherein 1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid is the compound administered.

12. A method according to claim 7 wherein 1-propyl-1,3,4,9,tetrahydropyrano[3,4-b]indole-1-acetic acid is the compound administered.

13. A method according to claim 7 wherein 1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid is the compound administered.

14. A pharmaceutical composition according to claim 8 wherein the compound of Formula 1b is 1-propyl-1,3,4,9,-tetrahydropyrano[3,4-b]indole-1-acetic acid.

15. A pharmaceutical composition according to claim 8 wherein the compound of Formula 1b is 1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid.

16. A pharmaceutical composition according to claim 9 wherein the compound of Formula 1b is 1-propyl-1,3,4,9,tetrahydropyrano[3,4-b]indole-1-acetic acid.

17. A pharmaceutical composition according to claim 9 wherein the compound of Formula 1b is 1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.